• 1
    Kinlen LJ. Immunosuppression and cancer. IARC Sci Publ 1992; 23753.
  • 2
    Harris NL, Swerdlow AJ, Frizzera G, Knowles DM. Pathology and genetics of tumors of haematopoietic and l ymphoid tissues. In: JaffeES, SteinH, VardimanJW, eds. World Health Organization classification of tumors, vol. 3. Lyon, France: IARC Press, 2001. 2649.
  • 3
    Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999; 12: 20017.
  • 4
    Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008; 112: 515060.
  • 5
    Kaldor JM, French MA. When do patients present with HIV infection? Med J Aust 1993; 158: 378.
  • 6
    McDonald AM, Crofts N, Blumer CE, Gertig DM, Patten JJ, Roberts M, Davey T, Mullins SE, Chuah JC, Bailey KA, Chuah JC. The pattern of diagnosed HIV infection in Australia, 1984–1992. AIDS 1994; 8: 5139.
  • 7
    van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 2009; 114: 6307.
  • 8
    van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, Grulich AE. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23: 218390.
  • 9
    Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006; 15: 6308.
  • 10
    Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadie M, Spinelli JJ, Costantini AS, Rudiger T, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110: 695708.
  • 11
    Breslow NE, Day NE. Statistical methods in cancer research. The design and analysis of cohort studies, vol. II. IARC Scientific Publications No. 82. Lyon: Oxford University Press, 1987.
  • 12
    Ducloux D, Carron PL, Racadot E, Rebibou JM, Bresson-Vautrin C, Saint-Hillier Y, Chalopin JM. CD4 lymphocytopenia in long-term renal transplant recipients. Transplant Proc 1998; 30: 285960.
  • 13
    Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 7637.
  • 14
    Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 5967.
  • 15
    de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005; 23: 635863.
  • 16
    Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006; 20: 164554.
  • 17
    Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 2008; 22: 3016.
  • 18
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol 2009; 27: 335462.
  • 19
    Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009; 113: 121324.
  • 20
    International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans: Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8, vol. 70. Lyon: IARC Press, 1997.
  • 21
    Tsao L, Hsi ED. The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Path Lab Med 2007; 131: 120918.
  • 22
    Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert JJ, Blattner WA. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997; 73: 64550.
  • 23
    Baecklund E, Sundstrom C, Ekbom A, Catrina AI, Biberfeld P, Feltelius N, Klareskog L. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003; 48: 154350.
  • 24
    Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer 2009; 124: 1497502.
  • 25
    Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. 9. IARC Scientific Publications No. 160. Lyon: IARC Press, 2007.
  • 26
    Tracey E, Alam N, Chen W, Bishop J. Cancer in New South Wales: incidence and mortality 2006. Sydney: Cancer Institute NSW, 2008.